Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hyperphagia × Other × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Other hematologic neoplasm 1 Other 1 Genitourinary 1

Conditions

Obesity 265 Mucositis 100 Neoplasms 99 Breast Neoplasms 80 Overweight 70 Sexual Dysfunction, Physiological 63 Polycystic Ovary Syndrome 62 Dyspnea 45 Motor Activity 40 Constipation 40 Head and Neck Neoplasms 37 Weight Loss 31 Prostatic Neoplasms 29 Pain 24 Stomatitis 23 Opioid-Induced Constipation 21 Endometrial Neoplasms 19 Multiple Endocrine Neoplasia Type 1 17 Lung Neoplasms 17 Diabetes Mellitus 16 Colorectal Neoplasms 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Sexual Dysfunctions, Psychological 14 Depression 14 Sedentary Behavior 13 Anxiety Disorders 13 Colonic Neoplasms 12 Cardiovascular Diseases 12 Cancer-related Fatigue 12 Sexuality 11

Interventions

fish oil triglycerides 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00533078 2015-07-23

LUNCH1

Insel Gruppe AG, University Hospital Bern

Phase 2 Completed

Colitis, Hyperphagia, Infections, Neutropenia, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡